Generic asthma inhaler study pulled before starting
NCT ID NCT07223294
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study aimed to see if a generic version of the asthma inhaler fluticasone furoate/vilanterol works as well as the brand-name Breo Ellipta in adults with asthma. Participants would have taken the inhaler daily for 4 weeks and used a rescue inhaler as needed. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sandoz Investigational Site
Cullman, Alabama, 35055, United States
-
Sandoz Investigational Site
Bradenton, Florida, 34208, United States
-
Sandoz Investigational Site
Leesburg, Florida, 34748, United States
-
Sandoz Investigational Site
Orlando, Florida, 32789, United States
-
Sandoz Investigational Site
St Louis, Missouri, 63141, United States
-
Sandoz Investigational Site
Raleigh, North Carolina, 27607, United States
Conditions
Explore the condition pages connected to this study.